Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1207853-15-3

Post Buying Request

1207853-15-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • SAGECHEM/benzyl (3R,4R)-3-amino-4-fluoropiperidine-1-carboxylate/SAGECHEM/Manufacturer in China

    Cas No: 1207853-15-3

  • No Data

  • No Data

  • No Data

  • SAGECHEM LIMITED
  • Contact Supplier

1207853-15-3 Usage

General Description

The chemical "1-Piperidinecarboxylic acid, 3-aMino-4-fluoro-, phenylMethyl ester, (3R,4R)-rel-" is a specific organic compound with the molecular formula C15H20FN3O2. It has a piperidine ring and a carboxylic acid functional group, as well as an amino and fluoro substituent. The phenylmethyl ester group is also present, with the (3R,4R)-rel- configuration specifying the stereochemistry of the molecule. 1-Piperidinecarboxylic acid, 3-aMino-4-fluoro-, phenylMethyl ester, (3R,4R)-rel- may have potential applications in medicinal chemistry and drug development due to its unique structure and properties.

Check Digit Verification of cas no

The CAS Registry Mumber 1207853-15-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,7,8,5 and 3 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1207853-15:
(9*1)+(8*2)+(7*0)+(6*7)+(5*8)+(4*5)+(3*3)+(2*1)+(1*5)=143
143 % 10 = 3
So 1207853-15-3 is a valid CAS Registry Number.

1207853-15-3Relevant articles and documents

MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES

-

, (2021/11/06)

The present disclosure relates to novel compounds for use in therapeutic treatement of a disease associated with peptidylarginine deiminases (PADs), such as peptidylarginine deiminase type 4 (PAD4). The present disclosure also relates to processes and intermediates for the preparation of such compounds, methods of using such compounds and pharmaceutical compositions comprising the compounds described herein.

AMINOPYRIDAZINONE COMPOUNDS AS PROTEIN KINASE INHIBITORS

-

Paragraph 00119; 00122, (2016/01/25)

The present disclosure provides a compound of formula (I) and the use thereof for the therapeutic treatment of human cancers including B-cell lymphoma and autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.

6 SUBSTITUTED 2-HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS

-

Page/Page column 130-132, (2010/04/03)

The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, their synthesis, and their use as CHK-1 inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1207853-15-3